Answers are grounded in this paper and cite their sources.
Observational findings link inflammatory markers to clinical outcomes in metastatic castration-resistant prostate cancer, suggesting their prognostic value.
Baseline inflammatory markers are associated with clinical outcomes for patients treated with ¹⁷⁷Lu-PSMA-617.
No takes yet. Share an insight, caveat, or question.
Gerke et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: